Use of short‐term efficacy/toxicity tradeoffs to select second‐line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

Arthritis & Rheumatism

Volumn 35, Issue 10, 1992, Pages 1117-1125

  Felson, David T ^a,b   Anderson, Jennifer J ^a,b   Meenan, Robert F ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AURANOFIN; AZATHIOPRINE; GOLD; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HUMAN; JOINT FUNCTION; LEUKOPENIA; LIVER TOXICITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ANTIMALARIALS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMAN; METHOTREXATE; SULFASALAZINE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026801236     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780351003     Document Type: Article

References (34)

1. The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis: results of two metaanalyses
2. A toxicity index for comparison of side effects among different drugs
3. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis Q J
4. Meta‐analysis in clinical trials
5. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: 14‐year prospective evaluation of 1017 consecutive starts
6. Gold induced thrombocytopenia: 12 cases and a review of the literature
7. Reversal of progressive, life‐threatening gold hypersensitivity pneumonitis by corticosteroids
8. Toxicity of D‐penicillamine in rheumatoid arthritis
9. Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis
10. Fatal polymyositis in D‐penicillamine‐treated rheumatoid arthritis
11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate
12. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors; four case reports and a review of the literature
13. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
14. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds‐Birminghamtrial
15. Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis
16. Degree and extent of response to sulphasalaz or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two‐year period
17. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine
18. A controlled trial comparing sulphasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis
19. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
20. Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty‐six‐week, double‐blind trial
21. Azathioprine in rheumatoid arthritis: a double‐blind, cross‐over study
22. Azathioprine in rheumatoid arthritis: double‐bind study of full versus half doses versus placebo
23. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report
24. Comparison of azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis (abstract)
25. A double‐blind controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriatic arthritis (abstract)
26. Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis
27. Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty‐six–week, double‐blind trial
28. Comparative controlled trial of low‐dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3‐year prospective study
29. Azathioprine in rheumatoid arthritis a double‐blind study comparing full dose to half dose
30. Degree and extent of response to sulphasalazine or penicilamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two‐year period
31. Radiological progression in rheumatoid arthritis: do D‐penicillamine and hydroxychloroquine have different effects?
32. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24‐month double‐blind, placebo‐controlled study
33. OM‐8980 and D‐penicillamine in the treatment of rheumatoid arthritis
34. Azathioprine in rheumatoid arthritis